New pill aims to help men last longer in bed
NCT ID NCT07047404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new drug called BP1.4979 can help men with lifelong premature ejaculation last longer during sex. Sixty men aged 18 to 50 will take either the drug or a placebo before sex for 12 weeks. Researchers will measure ejaculation time and check for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BP1.4979 (a dopamine D3 partial agonist)
What this could lead to
If it works, this could lead to a new on-demand treatment for primary premature ejaculation, giving men more control and longer time to ejaculation.
What could go wrong
This is an early Phase 2 trial with only 60 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE (EARLY) EJACULATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Nîmes
RECRUITINGNîmes, 30029, France
Contact